In the wake of a high-profile firing over ‘offensive’ language, followed by a $25 million lawsuit claiming wrongful termination, we examined the behavioral climate among healthcare agencies.
Brodeur Partners’ Lauren Levinson on transparency in healthcare proposals
With greater transparency of the cost and sale price of a drug must also come greater transparency of the inputs, ecosystem, and risk investment on which drug development relies.
Industry, government square off over list prices in DTC ads
There has been more intrigue and discussion about the point-of-care environment over the past 18 months than in the last decade combined — and the news keeps on coming.